Elekta International
Elekta Australia
Elekta Canada
Elekta China
Elekta Hong Kong
Elekta India
Elekta Japan
Elekta New Zealand
Elekta Singapore
Elekta United States
ELEKTA’S OPPONENT IN U.S.PATENT DISPUTE DENIED RECONSIDERATION
On Thursday October 30, 2003, theUnited States Court of Appeals for the Federal Circuit announcedits decision to deny the petition from Medical Instrumentationand Diagnostics Corporation (Midco), Elekta’s opponent inthe U.S. patent dispute, to reconsider its ruling issued onSeptember 22, 2003.
As a result the ruling by thecourt, which among other findings determined that none of Elekta’sproducts infringed the Midco patents and in which Elekta wasfreed from all liability, remains valid.
Midco may file a petition forreview (certiorari) with the United States Supreme Court. Grantof this remedy is very unusual.
The full opinion of the court fromSeptember 22 is available at www.fedcir.gov/dailylog.html, docket no. 03-1032.
For further information, pleasecontact:
Peter Ejemyr, Group VP Corporate Communications, Elekta AB (publ),
Phone: +46 8 587 254 00, e-mail: peter.ejemyr@elekta.com
Elekta is a world-leadingsupplier of advanced and innovative radiation oncology andneurosurgery solutions and services for precise treatment ofcancer and brain disorders. Elekta's solutions are clinicallyeffective, cost efficient and gentle to the patient.
For additional information about Elekta, please visit www.elekta.com
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
 |  |